Coherus Oncology, Inc. - CHRS
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 05, 2026 | SCHEDULE 13G | Timothy G. Youngquist 2020 Irrevocable Trust | 6.5% | 7,850,800 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | The Vanguard Group | 8.29% | 10,028,893 | View |
| Nov 04, 2025 | SCHEDULE 13G | Bering Partners II, L.P. ("Bering II") | 4.1% | 4,763,062 | View |
| Nov 04, 2025 | SCHEDULE 13G | Bering Partners II GP, L.L.C. ("Bering II GP") | 4.1% | 4,763,062 | View |
| Nov 04, 2025 | SCHEDULE 13G | Bering Partners III, L.P. ("Bering III") | 2.4% | 2,826,446 | View |
| Nov 04, 2025 | SCHEDULE 13G | Bering Partners III GP, L.L.C. ("Bering III GP") | 2.4% | 2,826,446 | View |
| Nov 04, 2025 | SCHEDULE 13G | Evgeny Zaytsev ("Zaytsev") | 6.5% | 7,602,708 | View |
| Nov 04, 2025 | SCHEDULE 13G | Philip Sawyer ("Sawyer") | 6.5% | 7,589,508 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.